UBC Antikörper (C-Term)
Kurzübersicht für UBC Antikörper (C-Term) (ABIN2852400)
Target
Alle UBC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with the C-terminus part of human UBC / Ubiquitin C
-
Aufreinigung
- Purified
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human Ubiquitin.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IHC-P10 μg/mL WB1:100 - 1:500 IF1:10 - 1:50 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.39 mg/mL
-
Buffer
- PBS, Sodium azide 0.09 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- UBC (Ubiquitin C (UBC))
-
Andere Bezeichnung
- UBC / Ubiquitin C
-
Hintergrund
- UBC protein is a polyubiquitin precursor. Conjugation of ubiquitin monomers or polymers can lead to various effects within a cell, depending on the residues to which ubiquitin is conjugated. Ubiquitination has been associated with protein degradation, DNA repair, cell cycle regulation, kinase modification, endocytosis, and regulation of other cell signaling pathways.
-
Gen-ID
- 7316
-
Pathways
- Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Activation of Innate immune Response, Mitotic G1-G1/S Phases, DNA Replication, Toll-Like Receptors Cascades, Synthesis of DNA, EGFR Downregulation, Ubiquitin Proteasome Pathway
Target
-